Discovery Partners Announces IPO

Discovery Partners International of San Diego announced on May 6 the initial public offering of 7,222,000 shares of its common stock at a price of $5 per share. The shares are being sold by Axys Pharmaceuticals, a stockholder of Discovery Partners, the company said.

SG Cowen & Co. is acting as lead manager of the offering, and Merriman Curhan Ford & Co and Roth Capital Partners are co-managers.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.